How Much, How Often, How Long? Addressing Dosage in Intervention Studies
In clinical drug efficacy trials, drug dose, dosing interval, and duration of treatment are all typically manipulated as independent variables to identify an optimal dosage for improving clinical outcomes. Dosage is also an important, if underemphasized, factor in educational, behavioral, and psychosocial intervention research. Dose refers to each intervention contact, dose intensity is the time elapsed between intervention contacts, and the duration of treatment is the time period over which the entire intervention was delivered.
Although trials examining the impact of drug dosage on clinical outcomes are ubiquitous in the health sciences, studies examining the effect of intervention dosage on educational, behavioral, and psychosocial outcomes are rare. In addition, many intervention studies inconsistently report details regarding intervention dosage, making it difficult to compare findings across studies. Intervention dose, dose intensity, and duration should be included in all research reports because dosing variations can mask meaningful results (Conn & Groves, 2011) .
Researchers who conduct intervention studies should use methods to analyze and report results showing the differential effects of dosage on outcomes if not all subjects received the same dosage. Although results are typically analyzed based by group assignment, in many studies, intervention dosage may vary across subjects despite investigators' best attempts to ensure treatment dose fidelity. For example, while the total duration of an intervention may have been consistent across subjects, the total number of doses or the dosing intensity may have varied. In these cases, further statistical analyses should be conducted to determine how these different aspects of intervention dosage affected outcomes.
Intervention dosing effects should always be assessed within the context of both specific and nonspecific intervention components. Specific factors are the intended, often theoretically derived intervention components being tested to produce a desired change in outcomes (Conn & Groves, 2011; Donovan, Kwekkeboom, Rosenzweig, & Ward, 2009; Whittemore & Grey, 2002) . Nonspecific factors include components that are not intentionally incorporated to impact outcomes but may nevertheless still exert an effect 605067WJ NXXX10.1177/0193945915605067Western Journal of Nursing ResearchEditorial editorial2015 Western Journal of Nursing Research 38(1) (Bootzin & Bailey, 2005; Donovan et al., 2009) . For example, the nature of the relationship between interventionists and subjects may affect outcomes, even though that relationship is not included as an active intervention ingredient (Bootzin & Bailey, 2005; Donovan et al., 2009 ). Strategies to detect nonspecific factors include the statistical assessment of mediating variables and outcome variables likely to be influenced by the nonspecific factors (Donovan et al., 2009) . Some nonspecific factors may be managed at the design stage by using attention control groups or placebo trials such that effects are identical across treatment groups. Researchers should acknowledge and attempt to manage nonspecific factors in their studies and resulting publications to address the dose of active ingredients of interventions.
Post hoc analyses of dosage variations can provide valuable information for future research and practice. An alternative approach is to address dosage during the design phase of a project by means of, for example, a multiphase optimization strategy (Collins, Murphy, Nair, & Strecher, 2005) . The dosing strategies that show the most potential can then be incorporated into a refined intervention that can be tested in the final confirming phase of the project.
Many researchers focus on examining how varying the content of educational, behavioral, and psychosocial interventions affects outcomes, but there is a definite need for more studies examining how varying intervention dosages affects outcomes. Careful management of all dose dimensions will allow researchers to more precisely determine the relative efficacy of different interventions to see which combinations of dose and content produce the best outcomes. Vicki S. Conn Keith C. Chan University of Missouri, Columbia, USA
